Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
1(5%)
Results Posted
50%(6 trials)

Phase Distribution

Ph phase_2
13
68%
Ph phase_4
1
5%
Ph not_applicable
1
5%
Ph phase_1
4
21%

Phase Distribution

4

Early Stage

13

Mid Stage

1

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
4(21.1%)
Phase 2Efficacy & side effects
13(68.4%)
Phase 4Post-market surveillance
1(5.3%)
N/ANon-phased studies
1(5.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

19

all time

Status Distribution
Active(4)
Completed(12)
Other(3)

Detailed Status

Completed12
Not yet recruiting3
unknown2
Suspended1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (21.1%)
Phase 213 (68.4%)
Phase 41 (5.3%)
N/A1 (5.3%)

Trials by Status

suspended15%
not_yet_recruiting316%
completed1263%
recruiting15%
unknown211%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT07203274Not Applicable

The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch

Not Yet Recruiting
NCT06810050Phase 2

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Completed
NCT06594393Phase 2

A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Recruiting
NCT07005180Phase 2

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Not Yet Recruiting
NCT07120308Phase 2

To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

Completed
NCT06812637Phase 1

Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Double-blinded Randomized Controlled Clinical Trial

Completed
NCT06058000Phase 2

A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis

Completed
NCT06678399Phase 1

Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Intravenous Administration of Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery

Not Yet Recruiting
NCT04520321Phase 1

A Phase 1/ Phase 2 Study of TTHX1114(NM141)

Completed
NCT03024255Phase 2

A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

Completed
NCT05234320Phase 1

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug

Unknown
NCT03850483Phase 2

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Completed
NCT03903822Phase 2

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

Completed
NCT01323673Phase 4

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

Completed
NCT01703793Phase 2

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

Completed
NCT00972777Phase 2

Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Completed
NCT01368887Phase 2

Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis

Suspended
NCT00557739Phase 2

Study of CRx-191 to Assess Activity in Plaque Psoriasis

Completed
NCT00485394Phase 2

The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)

Unknown

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19